Participated · Series B · Jun 2024

Polaris3D develops an AI autonomous robot platform centered on its proprietary KEPLER autonomous driving solution, applied to serving robots, delivery robots, and AMRs for logistics. The company holds 21 related patents and says KEPLER was developed without relying on open‑source software. It has introduced safe LFP batteries in its serving robot 'ereon' and implemented an AI vibration control suspension to improve ride smoothness. Polaris3D's R&D team is about 30 people, led by seven engineers with master’s and doctoral degrees from POSTECH who are directly involved in product development. The company plans broad exports this year to markets including the USA, Canada, Brazil, India, Southeast Asia (Indonesia, Vietnam), and European markets such as Hungary and Uzbekistan. With total capital now exceeding ₩21 billion, Polaris3D positions itself as a domestic alternative to Chinese service robots that occupy a large share of the local market.

Participated · Series B · Jun 2024

Nara Space specializes in small satellite manufacturing and data analytics for Earth observation. The company operates the 'Observer' EO satellite program and is developing a methane-monitoring satellite under the NarSha Project. Last November it developed and launched Observer-1A, becoming the first South Korean startup to launch a commercial 16U small EO satellite; Observer-1A performs daily observation missions in LEO and has been capturing images of major cities worldwide. With the new funding, Nara Space plans to launch the Observer-1B twin and lay foundations for a satellite mass production line. Management has set a goal to operate a cluster of 100 small satellites within the next five years to provide real-time global Earth monitoring services across different sensors and wavelengths. The company has now raised approximately $24.3 million to date following earlier pre-Series A and Series A rounds.

Participated · Series B · May 2024

HoneyNaps develops SOMNUM, an AI sleep diagnosis algorithm that analyzes biosignal data during sleep and provides disease diagnoses in under five minutes. The company obtained FDA approval for SOMNUM in 2023 and has partnered with major U.S. university hospitals via its Boston branch. HoneyNaps spent nine years developing X.AI (eXplainable AI), has registered 16 original patents and published SCIE-level research to support its clinical positioning. Management says domestic sales growth and export potential to the American medical market were key drivers of investor interest. The company plans to advance its AI beyond sleep diagnosis into applications such as cardiovascular disease, dementia, and Parkinson’s disease. Financially, HoneyNaps has raised about $16.2M to date, including seed funding of roughly $0.7M in 2019 and a $3.9M Series A in 2021.

Led · Series A · Feb 2024

According to the article headline, CloudHospital has completed a Series A financing that brings its total capital raised to 8.5 billion KRW. Beyond the funding announcement, the article does not provide specifics on the company’s core product, target market, or operating metrics. No information on revenue, user base, or growth trajectory was disclosed. Details about the company’s strategic plans for deploying the new capital were likewise absent. The identities of the founders, the year of establishment, and the company’s location were not mentioned. As such, the available information is limited strictly to the fact of the Series A raise and the cumulative funding figure.